Harmani Kalim MGF, Rohman MS, Sargowo D, Winarsih S, Nugrahenny D, Sujuti H, Widhaningrum SN, Souhaly JW. Empagliflozin Attenuates Cardiac Fibrosis via Suppression of TLR2/NF-κB Signaling in a Rat Model of Metabolic Syndrome. Trends Sci [Internet]. 2026Apr.10 [cited 2026Jun.24];23(9):13423. Available from: https://tis.wu.ac.th/index.php/tis/article/view/13423